Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $0.89 USD
Change Today -0.0135 / -1.49%
Volume 219.3K
HNSN On Other Exchanges
Symbol
Exchange
Frankfurt
As of 8:10 PM 07/6/15 All times are local (Market data is delayed by at least 15 minutes).

hansen medical inc (HNSN) Snapshot

Open
$0.89
Previous Close
$0.90
Day High
$0.92
Day Low
$0.85
52 Week High
08/27/14 - $1.33
52 Week Low
12/24/14 - $0.52
Market Cap
167.8M
Average Volume 10 Days
691.5K
EPS TTM
$-0.42
Shares Outstanding
188.5M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for HANSEN MEDICAL INC (HNSN)

Related News

No related news articles were found.

hansen medical inc (HNSN) Related Businessweek News

No Related Businessweek News Found

hansen medical inc (HNSN) Details

Hansen Medical, Inc. develops, manufactures, and sells medical robotics designed for the positioning, manipulation, and control of catheters and catheter-based technologies in the United States and internationally. It offers Sensei systems and Artisan Control Catheters for manipulation, positioning, and control of mapping catheters during electro-physiology procedures; and CoHesion 3D Visualization Module, a software interface that provides physicians with 3D visualization to augment their ability to move a catheter throughout the atria, as well as increase control over placement of the catheter in specific locations. The company also provides Magellan Robotic System, which controls the proprietary Magellan Robotic Catheter, a telescoping and robotically steerable catheter that facilitates remote catheter navigation and vessel cannulation, and provides robotically stabilized sheath for manual delivery of therapeutic devices. It markets, sells, and supports its products through direct sales force, distributors, and sales representatives. Hansen Medical, Inc. was founded in 2002 and is headquartered in Mountain View, California.

169 Employees
Last Reported Date: 03/16/15
Founded in 2002

hansen medical inc (HNSN) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $462.7K
Interim Chief Financial Officer, Principal Ac...
Total Annual Compensation: $467.9K
Chief Operating Officer
Total Annual Compensation: $420.0K
Senior Vice President of Marketing and Busine...
Total Annual Compensation: $298.5K
Senior Vice President of Global Sales
Total Annual Compensation: $296.6K
Compensation as of Fiscal Year 2014.

hansen medical inc (HNSN) Key Developments

Hansen Medical, Inc. Approves Alternate Amendments to the Company’s Certificate of Incorporation

Hansen Medical, Inc. approved alternate amendments to the company’s Certificate of Incorporation to, at the Discretion of the Board of Directors: the stockholders of the Company approved a series of alternate amendments to the company’s Certificate of Incorporation, to effect, at the discretion of the company’s Board of Directors a reverse stock split of the company’s common stock, whereby each outstanding four, six, eight, or ten shares would be combined, converted and changed into one share of common stock and a proportional reduction in the number of authorized shares of common stock with the effectiveness of one of such amendments and the abandonment of the other amendments, or the abandonment of all amendments, to be determined by the company’s Board of Directors prior to the company’s 2016 annual meeting of stockholders. The company also approved amendment to the company’s certificate of incorporation to increase the company’s total number of authorized shares from 210,000,000 to 310,000,000.

Hansen Medical, Inc. Reports Unaudited Consolidated Earnings Results for the First Quarter Ended March 31, 2015

Hansen Medical, Inc. reported unaudited consolidated earnings results for the first quarter ended March 31, 2015. For the quarter, the company reported total revenue of $5.8 million, an increase of 57% compared with $3.7 million for the same period in 2014. Net loss was $11.9 million, or $0.09 per share, compared to a net loss of $14.4 million, or $0.14 per share, for the same period in 2014. Loss from operations was $8,981,000 compared to $13,178,000 a year ago. Loss before income taxes was $11,924,000 compared to $14,427,000 a year ago. Non-GAAP loss from operations was $8,256,000 compared to $11,922,000 a year ago. Non-GAAP net loss was $9,532,000 compared to $13,189,000 a year ago. Non-GAAP diluted net loss per common share was $0.07 compared to $0.13 a year ago.

Hansen Medical Not In Compliance With Nasdaq Listing Rule

On April 13, 2015 Hansen Medical, Inc. was notified by the Nasdaq Stock Market that it is not in compliance with the continued listing requirements for the Nasdaq Global Select Market contained in Nasdaq Listing Rule 5450(a)(1) requiring the Company's listed securities to have a minimum bid price of $1.00 per share for 30 consecutive trading days. The notification letter does not impact the Company's listing on the Nasdaq Global Select Market at this time. In accordance with Nasdaq Listing Rule 5810(c)(3)(A), the Company has been provided 180 calendar days, or until October 12, 2015, to regain compliance with Nasdaq Listing Rule 5450(a)(1). To regain compliance, the Company's common stock must have a closing bid price of at least $1.00 for a minimum of 10 consecutive business days. In the event the Company does not regain compliance by October 12, 2015, the Company may be eligible for an additional 180-day grace period to regain compliance. The Company is considering available options to resolve the noncompliance with the minimum bid price requirement, which may include a reverse stock split. There can be no assurance that the Company will be able to regain compliance with the minimum bid price requirement or will otherwise be in compliance with other NASDAQ listing criteria.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
HNSN:US $0.89 USD -0.0135

HNSN Competitors

Market data is delayed at least 15 minutes.

Company Last Change
ABIOMED Inc $65.70 USD +0.49
Corindus Vascular Robotics Inc $4.06 USD +0.50
LeMaitre Vascular Inc $11.59 USD +0.29
Stereotaxis Inc $1.45 USD -0.04
Spectranetics Corp/The $23.54 USD +1.50
View Industry Companies
 

Industry Analysis

HNSN

Industry Average

Valuation HNSN Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 5.6x
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales 2.9x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact HANSEN MEDICAL INC, please visit www.hansenmedical.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.